Surrogacy Legality in China and Abroad: Contracts and Child Documents in 2026

The legality of surrogacy cannot be reduced to one word. In mainland China, medical institutions and medical professionals may not carry out any form of surrogacy technology, and the sale of gametes, zygotes or embryos is prohibited. Yet intended parents, introducers, medical personnel, document handlers and payment intermediaries do not incur responsibility on the same legal basis. Permission in a foreign jurisdiction also does not automatically secure the agreement, parentage, nationality, travel documents or recognition at home.

A workable international arrangement must pass five separate reviews: medical regulation where conduct occurs; the civil effect of each agreement; administrative or criminal exposure created by specific acts; the place-of-birth rules on parentage and registration; and the home country's determination of nationality, travel documentation and use of foreign records. A gap in any layer can stop the arrangement at payment, pregnancy, birth or return.

1. The direct answer: this is neither one offence nor one licence

China's current regulatory framework expressly prohibits medical institutions and medical professionals from implementing surrogacy technology. A joint programme issued by the National Health Commission and thirteen other departments also identifies surrogacy, trading in gametes and false or traded birth certificates as enforcement priorities. The authorities therefore examine the operational chain, not merely whether the word surrogacy appears in a contract.

For an intended parent, that rule does not support the conclusion that everything is risk-free once the procedure occurs abroad. Nor does it make every participant liable for the same crime. Analysis depends on the person's role, the place of conduct, medical acts, organisation of transactions, false documents, money flow and any interference with the rights of women or children.

2. Mainland China: implementation is prohibited, while responsibility remains conduct-specific

Article 3 of the Administrative Measures for Human Assisted Reproductive Technology requires ART to be performed for medical purposes in medical institutions. It prohibits any sale of gametes, zygotes or embryos and states that medical institutions and medical professionals may not implement any form of surrogacy technology. This directly regulates providers and is a central benchmark for the lawfulness of related services.

One programme may involve consultation, introduction, egg retrieval, embryo handling, pregnancy management, payments, document applications and cross-border transport. Different rules govern each step. Unlicensed diagnosis or treatment raises healthcare and illegal-practice issues; trading in reproductive material is expressly prohibited; and false medical records, birth certificates or state documents engage separate administrative and criminal rules.

The fact that an intended parent did not personally perform a medical act is not a complete safety analysis. Organising domestic procedures, arranging unlicensed premises, assisting identity misuse, purchasing false documents, controlling another person's liberty or participating in unexplained money flows creates risk through those acts. Merely reading public information is not the same conduct and should not be conflated with it.

It is inaccurate to say that surrogacy in China creates only an administrative penalty, because associated conduct may create other liability. It is equally inaccurate to say that every intended parent necessarily commits a crime. The precise statement is that medical institutions and medical professionals may not implement surrogacy technology, while each act in the broader chain must be assessed on its own facts.

3. Contract effect: signature, notarisation and foreign governing law do not guarantee enforcement

Article 153 of the Civil Code and the Supreme People's Court's interpretation on the general contract rules require review of mandatory law and public order or good morals. Courts consider transaction purpose, regulatory intensity, repetition and social consequences. Because a surrogacy agreement affects bodily autonomy, medical decisions, parentage, child welfare and commercial payments, it cannot be treated as an ordinary brokerage agreement.

Choosing foreign law, selecting overseas arbitration or obtaining a foreign company's stamp addresses only part of governing law and procedure. It does not displace mandatory regulation where conduct occurs or bind a hospital, surrogate, registry, consulate or border authority that did not sign. Notarisation usually verifies execution or form; it is not a universal approval of substantive legality.

Invalidity, partial invalidity, impossibility of continued performance and breach are different legal states. Even if the core arrangement cannot be compelled, paid sums, reasonable expenses, fault, return of personal data and the child's immediate care may still require separate treatment. A clause stating that all fees are non-refundable or all outcomes are the client's risk is not automatically conclusive.

Pregnancy-related care must remain based on the pregnant woman's informed consent and a physician's judgment. Restrictions on healthcare or movement, mandatory delivery methods, forced fetal reduction or penalties designed to compel treatment can conflict directly with dignity, bodily rights and medical ethics. An intended outcome does not create control over another person's body.

Medical, legal, programme-management, accommodation, interpretation and escrow arrangements should be reviewed separately. Separation is not valuable because it produces more pages. It ensures that each actor undertakes only matters within its licence and control, rather than allowing one intermediary to promise the performance of every independent participant.

4. Foreign permission does not guarantee recognition at home: five gates remain

Surrogacy systems differ widely. Some jurisdictions permit commercial or compensated arrangements, some permit only altruistic arrangements, some restrict access to married opposite-sex couples or applicants with a medical indication, some have closed new programmes to foreigners, and others rely on state law, court orders or administrative practice. Outcomes may differ within one country and by identity or signing date.

Legality in the destination must be established through current legislation, implementing rules, competent authorities and a written opinion from qualified local counsel. A clinic licence, marketing page or earlier successful case does not prove that the present applicant qualifies. Where reforms include transition rules, the agreement must actually fall within the defined transitional category.

The Hague Conference on Private International Law continues to study cross-border recognition of legal parentage. Its public 2026 status shows that states have not adopted a unified convention on recognition, and the proposed instrument did not proceed to a drafting Special Commission at that stage. A parentage decision in one country therefore cannot be presumed automatically effective elsewhere.

A programme can be permitted locally but still unavailable to a particular family. Marriage documents, genetic links, settled status, court jurisdiction, birth-record format or consular requirements can close a route. Planning must begin with the applicant's actual identity configuration, not a completion story from another family.

5. Provider and payment due diligence: align the brand, legal entity and receiving account

International arrangements usually involve a clinic, laboratory, local lawyer, coordination company, interpreter, accommodation provider, insurer or escrow agent. The public-facing brand may differ from the contracting party, recipient and actual provider. Due diligence begins by placing every actor on one responsibility map, not by accepting a screenshot of one business certificate.

Clinic review should cover the legal name, licence number, authorised techniques, address, professional registration, laboratory ownership, sample-identification rules, access to records and emergency referral. A licensed clinic does not mean an intermediary may bind it on price, success rate, medication, surrogate management or birth documentation.

Legal counsel should disclose registration, mandate, client identity, conflicts, factual assumptions and date of the opinion. One lawyer purporting to represent every party with different interests weakens independence. The surrogate should have a genuine opportunity for separate advice and understanding.

Payments should use contractual corporate or regulated accounts and correspond to budgets, milestones, invoices and actual services. Personal accounts, cash, underground exchange, virtual assets or layered transfers with an unexplained beneficial owner increase fraud, refund, foreign-exchange, tax and anti-money-laundering risk. The recipient must match the contractual duty before funds move.

High-risk marketing follows a pattern: local availability becomes global legality; an old case becomes current policy; probability becomes guaranteed success; government review becomes guaranteed issuance; and personal access becomes an internal channel. A responsible provider does not promise a hospital decision, pregnancy outcome, judgment or consular review that it cannot control.

6. The child's document chain: birth record, parentage, nationality and travel are separate

There is no single return-home certificate. The chain commonly includes the hospital's primary record, civil birth registration, recognition of legal parentage, nationality determination, passport or travel document, any required visa, and authentication, Apostille or translation for use in another country. Each step has a different authority and evidentiary purpose.

A birth record first documents the time, place and person giving birth under local rules. Whether intended parents appear directly depends on local law, court orders, consent and registry practice. Their names are important evidence, but the document cannot be separated from its legal basis and assumed to settle parentage everywhere.

Legal parentage is not identical to genetic relationship. DNA can evidence a biological connection but does not alone decide parental responsibility, the position of a non-genetic spouse, post-birth consent by the surrogate or procedures required by a court or registry.

Chinese nationality is determined under the Nationality Law. Article 5 requires examination of whether one or both parents are Chinese nationals, whether a Chinese parent is settled abroad, and whether the child acquired a foreign nationality at birth. Genetics, place of birth, parental identity and settled status must be assessed together; a Chinese father or a foreign birth certificate does not by itself settle the issue.

Passports, travel documents and visas govern travel and entry. A nationality conclusion does not mean a document will issue without original birth records, parentage evidence and identity review. The absence of one nationality does not automatically produce another passport. The route should be checked with the competent authority before the programme starts.

Medical Certificates of Birth and other medical certificates must be based on genuine attendance, delivery and records. The National Health Commission continues to require truthful issuance and record management. Identity substitution at admission, fabricated delivery records, blank certificates or altered parental details are not supplementary paperwork; they are independent high-risk acts.

The child's interests remain central regardless of contract or payment disputes. A child should not lose care, healthcare, identity records or safety because adults made errors. Agreements need contingency care for delayed arrival, relationship breakdown, changed consent, health complications and document delay.

7. Administrative and criminal risks that require separate identification

Administrative and criminal exposure usually comes from conduct that can be described independently. A sound analysis identifies the act, actor, place, amount, evidence and consequence before considering the relevant regulatory field.

The joint enforcement programme notes that illegal ART may be accompanied by false birth certificates, intentional injury, unlawful detention and trafficking. This does not mean every surrogacy arrangement constitutes those offences. It means an opaque chain can intersect with them and must be designed to prevent that intersection.

A 2025 case published by the Zhangshu People's Procuratorate concerned a person who claimed she could provide surrogacy and obtained RMB 1.154 million through fabricated examination, nutrition and deposit demands. The fraud conviction does not turn every surrogacy dispute into fraud; it confirms that sensitivity of the service does not shield deliberate deception.

Personal data also requires separate protection. Passports, marriage records, clinical files, genetic tests, embryo identifiers, surrogate identity and child records are highly sensitive. Providers should define purpose, access, cross-border transfer, retention, incident response and deletion, rather than circulating them through public links or large chat groups.

8. The complete pre-execution sequence

Assessment should start with identity and objective, not package price. Establish marriage, nationality, residence, intended genetic links and the country of return, then screen jurisdictions and procedures. When the order is reversed, families often discover a closed eligibility or document route only after payment or embryo creation.

Every key conclusion should record the source, publication date, verification date and assumptions. Opinions, consular checklists, licences and bank accounts can change. Preserve the URL, full document, issuing authority and later written confirmation, not only a screenshot. Where language versions differ, designate the controlling text and obtain professional translation review before signing.

Payment and medical arrangements should pause if eligibility exists only in an intermediary's oral explanation; local counsel will not disclose registration; the clinic licence cannot be independently checked; the contracting party and account differ; the surrogate has no independent advice; documents are unconditionally guaranteed; or key requirements are answered with a promise to use connections later.

Families already in a programme can still conduct the review. First preserve contracts, payments, clinical records, sample records and identity documents; identify every actor; then complete local legal and post-birth document analysis. Do not fabricate missing evidence or continue large payments without a written basis.

9. Conclusion: convert legality into a verifiable set of legal questions

Mainland China expressly prohibits medical institutions and medical professionals from implementing any form of surrogacy technology and prohibits trading in gametes, zygotes and embryos. Introduction, medical conduct, payment, documentation and control of persons must be assessed separately for civil, administrative and criminal consequences.

Local permission abroad is only a starting point. Applicant eligibility, medical authority, agreement form, surrogate rights, birth registration, legal parentage, nationality, travel documents and use at home must each close. No provider can replace a court, registry, consulate or border authority with one contract or marketing statement.

A final decision should be based on the applicant's facts and confirmed separately by destination counsel, home-country counsel, licensed medical providers and competent authorities. The factual rules in this guide were reviewed through 5 August 2026; action should rely on the valid text and written authority requirements on the day of filing.